We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – Products

Cancer cells.
Product News

Xsphera Biosciences and NEX-I Collaborate To Advance Oncology Drug Research

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.
Product
Advertisement

CAR-T Target Luciferase Reporter Cells

CAR-T Target Luciferase Reporter Cells that have high endogenous expression of CD19, CD20, and HER2, which makes them more physiologically relevant as in vitro tools to develop adoptive CAR-T cell therapies.
A doctor holding a clipboard with a patient.
Product News

OncoHost To Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients

Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.
Cells.
Product News

Laverock Therapeutics Secures Innovate UK Award To Advance Immune Effector Cell Therapeutics Programme

Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.
NK Cell (Natural Killer Cell) Attacking a Cancer Cell stock photo
Whitepaper

Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.
Representation of human cells.
Product News

Curiox Biosystems To Advance Next-Generation Cancer Cell Therapies Through Collaboration With Leading Cancer Researcher

Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.
The Gibco CTS Detachable Dynabeads.
Product News

Accelerating Cell Therapies with Manufacturing Breakthrough

Thermo Fisher announced a first of its kind technology to help accelerate the molecule-to-market process by driving efficiency and reducing manufacturing costs.
Comprehensive CAR-T Therapy Solutions
Product
Advertisement

Comprehensive CAR-T Therapy Solutions

With six CAR-T drugs currently approved by the FDA and more to follow, Sino Biological has committed to developing reagents and services to support our clients in CAR development, CAR-T preparation and lentivirus packaging, CAR-T cell expansion, and CAR-T quality control.
Cytokines for Cell Therapy Research
Product
Advertisement

GMP-Grade Cytokines for Cell Therapy Research

Sino Biological performs extensive quality control tests to ensure that GMP-grade cytokines meet rigorous quality standards, offering a range of GMP-grade cytokines
View the Webinar Focus on Cytokines Therapies
Product
Advertisement

View the Webinar Focus on Cytokines Therapies

During this webinar, we will provide a comprehensive overview of several cytokine therapy approaches, development, and clinical application. We will further discuss how Sino Biological can assist in cancer immunotherapy research.
Advertisement